Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Neuphoria Therapeutics Inc. (NEUP) Debt to Equity Ratio data is not available for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
$15.65M |
|
$-0.37M |
|
-- |
|
$15.65M |
|
$16.78M |
|
$-1.13M |
|
$0.29M |
|
$-0.84M |
|
$-0.84M |
|
$-0.37M |
|
$-0.37M |
|
$-0.37M |
|
$-0.37M |
|
$-1.13M |
|
$-0.47M |
|
1.62M |
|
1.62M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$15.04M |
|
$0.00M |
|
$13.55M |
|
$28.59M |
|
$4.22M |
|
-- |
|
$5.37M |
|
$9.59M |
|
$19.00M |
|
$5.56M |
|
$19.00M |
|
1.98M |
|
| Cash Flow Statement Financials | |
$0.08M |
|
-- |
|
$1.53M |
|
$12.69M |
|
$14.29M |
|
$1.60M |
|
$0.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.56 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
100.00% |
|
-7.21% |
|
-7.21% |
|
-2.98% |
|
-5.35% |
|
-2.36% |
|
$0.08M |
|
-- |
|
-- |
|
-- |
|
0.55 |
|
-- |
|
1309.80 |
|
0.28 |
|
-1.95% |
|
-6.65% |
|
-1.29% |
|
-1.95% |
|
$9.61 |
|
$0.05 |
|
$0.05 |
|